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IL-8 Induces a Transient Arrest of Rolling Eosinophils on
Human Endothelial Cells1
Laurien H. Ulfman, Dianne P. H. Joosten, Jan A. M. van der Linden, Jan-Willem J. Lammers,
Jaap Jan Zwaginga, and Leo Koenderman2
Eosinophils exhibit a rolling interaction with E-selectin-expressing endothelium, and need to be activated by inflammatory me-
diators to firmly adhere to this surface. This study shows that IL-8 induces a transient arrest of unprimed eosinophils that roll on
E-selectin present on TNF-a-activated HUVEC in an in vitro flow chamber. This process was antagonized by neutralizing Abs
directed against IL-8 showing the specificity of the IL-8 effect. Furthermore, blocking Abs against both a4 and b2 integrins
inhibited the IL-8-induced transient arrest while these Abs had no effect when they were added separately. The IL-8-induced
arrest was pertussis toxin sensitive. Studying the effect of IL-8 in more detail, we evaluated putative changes in intracellular Ca21
concentration in eosinophils induced by IL-8. We could show that IL-8 induces a transient rise in intracellular Ca21 concentration
in ;40% of the cells provided that the eosinophils are interacting with endothelial cells or fibronectin-coated surfaces. Together
these data show that resting eosinophils respond to IL-8 provided that the cells adhere on physiological surfaces. The induction
of a transient arrest provides a new level of chemokine-induced regulation of leukocyte adhesion under flow conditions. The
Journal of Immunology, 2001, 166: 588–595.
E osinophils play an important role in allergic inflammatorydiseases like asthma. Infiltrates of these cells are presentin the structures of the airway wall and the lumen of the
bronchi of these patients (1). To enter the site of inflammation,
eosinophils have to leave the bloodstream and pass the endothe-
lium. A widely accepted paradigm for leukocyte extravasation is
referred to as the multi-step model (2). In this model, selectins and
their carbohydrate-bearing ligands mediate rolling interactions be-
tween leukocytes and the endothelium. In this respect, E-selectin,
which is present on activated endothelium, has been shown to me-
diate the rolling of neutrophils (3) and eosinophils (4). Subse-
quently, cells can be activated upon interaction with inflammatory
mediators resulting in the activation of integrins that bind to their
ligands expressed on the endothelium. In this way, firm adhesion
of the cells to the endothelium is established (5, 6).
An important class of inflammatory mediators involved in the
arrest of inflammatory cells are chemokines that are released at the
site of inflammation. Chemokines can be divided in four different
groups: C, CC, CXC, and CX3C in which X is the number of
amino acids in between cysteine residues at the NH2-terminal site
of the molecule. Of the C and CX3C families only one member of
each group is described, lymphotactin (7) and fraktalkine (8), re-
spectively. CC chemokines, including eotaxin, RANTES, and
monocyte chemoattractant protein-3, have been reported to be
mainly chemotactic for monocytes, lymphocytes, and eosinophils.
CXC chemokines, including IL-8 and growth-related oncogene-a,
have been shown so far as more specific for neutrophils (see Refs.
9 and 10 for reviews).
However, several clinical studies indicate that expression of the
CXC chemokine IL-8 is enhanced both at the level of mRNA and
protein in pulmonary “eosinophilic” diseases such as asthma (11–
13). IL-8 has been shown to be produced by bronchial epithelium
cells of asthmatic patients (11). Other sources for IL-8 include
endothelial cells, fibroblasts, macrophages, and mast cells (see
Ref. 12 for review). These cells play a key role in the pathogenesis
of allergic asthma. Many studies are designed to link the produc-
tion of different chemokines to the occurrence of inflammatory
cells in the tissues. As allergic asthma is characterized by a clear
eosinophilic inflammation in the bronchial tissue, several studies
evaluated the role for IL-8 in eosinophil activation and migration
processes in vitro and in vivo. No clear consensus is present con-
cerning this issue. Some in vitro studies on IL-8-induced eosino-
phil chemotaxis failed to show an IL-8-dependent effect on eosin-
ophil migration (14), whereas other reports did. These latter
studies were performed with cytokine-activated or “primed” eo-
sinophils (15, 16) or cells from allergic asthmatic (17) or eosino-
philic (18) subjects. In most of these studies, the effect of IL-8 on
eosinophils has been determined by the use of chemotaxis assays
such as the Boyden chamber. Subtle differences in experimental
set up (e.g., choice of filters, medium, etc.) might explain differ-
ences in outcome between the different studies. In addition to these
in vitro studies, the effect of IL-8 on eosinophils has also been
suggested by an in vivo study that showed that provocation with
IL-8 induces eosinophilia in the nasal epithelium (19).
Chemokines are ligands for G protein-coupled serpentine recep-
tors. On neutrophils, two high-affinity G protein-coupled receptors
for IL-8 have been described, CXCR1 and 2 (20, 21). When che-
mokines bind to their receptor, an increase of intracellular free
Ca21 concentration ([Ca21]i)3 is elicited. Increased [Ca21]i leads
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to multiple downstream signaling events and these have been cor-
related with a number of cellular functions (22). It has been ques-
tioned whether eosinophils can increase [Ca21]i upon IL-8 stim-
ulation because these changes in [Ca21]i were very small (15).
Indeed, Petering et al.(41) contributed these small changes to the
contamination of neutrophils. Remarkably, all studies that failed to
show the effect of IL-8 on [Ca21]i mobilization in eosinophils
were performed on cells in suspension. Migration studies, in con-
trast, show that eosinophils can respond to IL-8, and in these ex-
periments cells adhere to substrates. We hypothesized that eosin-
ophils that adhere to physiological substrates are more susceptible
for IL-8 stimulation compared with cells in suspension. Therefore,




Percoll was obtained from Pharmacia (Uppsala, Sweden). fMLP was pur-
chased from Sigma (St. Louis, MO). Human serum albumin (HSA) was
purchased from the Central Laboratory of the Netherlands Red Cross
Blood Transfusion Service (Amsterdam, The Netherlands). Recombinant
human TNF-a was purchased from Boehringer Mannheim (Mannheim,
Germany). IL-8 (72 aa) was obtained from PeproTech (Rocky Hill, NJ) and
eotaxin-1 was obtained from R&D Systems (Minneapolis, MN). Pertussis
toxin (PTX; 50 mg/ml) was obtained from Sigma. Incubation buffer con-
tained 20 mM HEPES, 132 mM NaCl, 6 mM KCl, 1 mM MgSO4, 1.2 mM
KH2PO4, supplemented with 5 mM glucose, 1.0 mM CaCl2, and 0.5%
(w/v) HSA. All other materials were reagent grade.
Antibodies
The mAb HP2/1 (anti-very late Ag-4, CD49d) was purchased from Immu-
notech (Marseille, France). mAb IB4 was isolated from the supernatant of
a hybridoma obtained from the American Type Culture Collection (Rock-
ville, MD). The Abs we used against a4 integrins (HP2/1) and b2 integrins
(IB4) are described as functional blocking Abs (23–26) Therefore, Ab-
induced differences in function of the eosinophils (e.g. by crosslinking of
integrins) seem to be unlikely. Control Ab W6/32 (anti-HLA-A, -B, -C)
was isolated from the supernatant of a hybridoma obtained from the Amer-
ican Type Culture Collection. Anti-CXCR1 and 2 Abs, 5A12 and 6C6
(PharMingen, San Diego), respectively, are described as blocking mAbs of
neutrophil migration (27). Anti-E-selectin mAb BBIG-E4 (5D11) was pur-
chased from R&D Systems (Abingdon, U.K.). mAbs were incubated with
eosinophils (4 3 106 cells/ml) at 10 mg/ml for 15 min before the experi-
ments. The cell suspensions were diluted twice with incubation buffer (final
concentration of 5 mg/ml mAb at 2 3 106 cells/ml in incubation buffer),
and the coverslips were placed directly in the system. Anti-IL-8 (clone
B-K8, BioSource International, Camarillo, CA) was added to IL-8 1028 M
in a final concentration of 20 mg/ml.
Isolation of eosinophils
Blood was obtained from healthy volunteers from the Red Cross Blood
Bank (Utrecht, The Netherlands). Mixed granulocytes were isolated from
the buffy-coat of 500 ml of blood anti-coagulated with 0.4% (w/v) triso-
dium citrate (pH 7.4) as previously described (28). Mononuclear cells were
removed by centrifugation over 1.077 g/ml isotonic Ficoll. After lysis of
the erythrocytes with an isotonic ice-cold NH4Cl solution, the granulocytes
were washed and resuspended in RPMI 1640 (Life Technologies, Paisley,
U.K.) with 0.5% (w/v) HSA.
Granulocytes were incubated for 30 min at 37°C to restore the initial
density of the cells. Thereafter, the cells were washed and resuspended in
PBS supplemented with 0.5% HSA and 13 mM trisodium citrate, and in-
cubated with 10 nM fMLP for 10 min at 37°C, to decrease the specific
gravity of the neutrophils, but not that of the eosinophils. Subsequently,
eosinophils were obtained by centrifugation (20 min; 1000 3 g) over iso-
tonic Percoll (density 1.082 g/ml, layered on Percoll with a density of 1.1
g/ml), washed, and resuspended in incubation buffer. Purity of eosinophils
was .95%. This procedure leads to the isolation of relatively unprimed
eosinophils compared with conventionally used isolation procedures with
immunomagnetic beads (29).
Endothelial cells
HUVEC were isolated from human umbilical cord veins according to Jaffe
et al. (30), with some minor modifications (31). The cells were cultured in
RPMI 1640 containing 20% (v/v) heat-inactivated human serum, 200
mg/ml penicilin/streptomycin (Life Technologies, Breda, The Nether-
lands), and Fungizone (Life Technologies). Cell monolayers were grown to
confluence in 5–7 days. Endothelial cells of the second passage or third
passage were used in perfusion assays. HUVEC was activated by 100 U/ml
TNF-a (7 h, 37°C) before the perfusion experiments.
Perfusion chamber
Perfusions under steady flow were performed in a modified form of trans-
parent parallel plate perfusion chamber (32) as previously described by
Van Zanten et al. (31). This microchamber has a slit height of 0.2 mm and
width of 2 mm. The chamber contains a circular plug on which a coverslip
(18 mm 3 18 mm) with confluent HUVEC was mounted. Immediately
after mounting the HUVEC, which was activated with TNF-a for 7 h, the
flow chamber was flushed with HEPES buffer for 2 min to wash out re-
sidual TNF-a.
Eosinophil perfusion and evaluation
Eosinophil perfusions were performed as described (4). In short, eosino-
phils in suspension (2 3 106 cells/ml in incubation buffer) were aspirated
from a reservoir through plastic tubing and the perfusion chamber with a
Harvard syringe pump (Harvard Apparatus, South Natick, MA). The indi-
vidual runs occurred under specific shear conditions all in a 37°C temper-
ature box. Perfusion experiments were recorded on video tape. The eosin-
ophil suspension was perfused during 3 min at shear stress 0.8 dyn/cm2 to
obtain an endothelial surface with firmly adhering and rolling eosinophils
(4). After these 3 min, buffer was added and shear stress was increased to
2 dyn/cm2. After 20 s at shear stress 2 dyn/cm2 recording of the images on
video was started. Subsequently, HEPES buffer containing 1028 M IL-8 or
1028 M eotaxin was added to the flow chamber. During the whole perfu-
sion experiment, Abs (10 mg/ml IB4, 10 mg/ml HP2/1, 20 mg/ml anti-IL-8,
or 10 mg/ml W6/32) were present. After ;30 s, the cytokine buffer reached
the cells and the cells arrested. Subsequently it took 30 s to ;2 min for the
cells to start rolling again. Therefore, the percentage of rolling cells was
determined at the following points: “before” stimulation, at time point 30 s
before addition of the cytokine-containing buffer; “during” stimulation, at
the time point that cytokine-containing buffer has reached the cells and the
cells arrest; and “after” stimulation, at the time point 1 min after the cy-
tokine-containing buffer reached the cells. Only one randomly chosen im-
age per experiment was recorded. Cells that started rolling again after the
IL-8-induced arrest rolled out of the recorded image, but also cells at the
front of the image rolled into the recorded image. Therefore, we calculated
the total amount of adhering cells present in the field before, during, and
after stimulation, which did not differ significantly in all tested circum-
stances. More than 90% of the firmly adherent cells under baseline con-
ditions were stable throughout the whole observation period when no cy-
tokine was added (results not shown). Also, of the stable stationary cells in
the before period, ,5% of the cells started rolling again after addition
of IL-8.
To automatically determine the percentage of rolling cells, custom-
made software was developed in Optimas 6.1 (4). In short, a sequence of
50 frames representing an adjustable time interval was digitally captured.
The velocity of each cell was calculated. The cut-off value to distinguish
between rolling and static adherent cells was set at 1 mm/sec. With this
method, static adherent, rolling, and freely flowing cells (which were not in
focus) could be clearly distinguished.
Flow cytometry
Flow cytometry analyses was conducted as described before (33). b2 in-
tegrins (IB4), CXCR1 (5A12), CXCR2 (6C6), or a control Ab (5D11 anti-
E-selectin) were used as primary mAbs. Granulocytes were analyzed using
a FACSvantage flow cytometer (Becton Dickinson, Mountain View, CA).
Imaging of intracellular free Ca21
Imaging of intracellular free Ca21 was performed with a custom-built
setup, consisting of a computerized excitation filter switcher (Lambda-10;
Sutter Instruments, Novato, CA) with excitation filters (D340/10 and
D380/13; Chroma Technology, McHenry, IL) coupled to a Leica (Wetzlar,
Germany) Leitz DMIL inverted microscope, which was equipped with
light filters appropriate for fura-2 (D510/40 and 400DCLP; Chroma Tech-
nology), a high immersion objective (UV-F 340 nA 1.30 glycerol immer-
sion; Nikon, Tokyo, Japan), and a Xenon arc lamp (XBO 75 W/2; Osram,
Berlin, Germany). A series of 50 image pairs (512 3 512, ;1 s apart) were
sequentially grabbed with a black and white framegrabber (Pulsar, Matrox
Electronic Systems, Dorval Quebec, Canada) from an intensified video
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camera (LI-mCAM; Lambert Instruments, Leutingewolde, The Nether-
lands) directly into computer memory. Ratios and calcium values were
computed off-line with Image Analysis software (Optimas 6.1; Media Cy-
bernetics, Silver Spring, MD) using custom-made macros (Arithmatic Lan-
guage for Images). Calcium levels were calculated with the standard cal-
ibration formula of Grynkiewics et al. (34)as follows with parameters of Kd
5 225 nM and b 5 2.4, and displayed in false colors (blue-red ramp):
[Ca21]i 5 Kd 3 b 3 (R 2 Rmin)/(Rmax 2 R). Cell calcium was separated
from background calculating the threshold mask from the mean of the two
ratio images for each of the 50 ratio images in the series. Threshold level
was obtained by choosing the first and the last level in the series, and then
by linear interpolation for the rest of the series, thereby counteracting the
effect of bleaching over time. Intracellular [Ca21] levels are determined by
calculating the mean [Ca21]i of all pixels in a cell in each of the 50 ratios
taken. The cut-off value to distinguish between a responding and a nonre-
sponding cell was set at a mean value of 200 nM. Figs. 4 and 6 show the
mean [Ca21]i of all cells exceeding this cut-off value. In the experiments
investigating the IL-8-induced increase in [Ca21]i, eotaxin was given after
the IL-8. The cells that did not respond to eotaxin (likely to be neutrophils)
were excluded from analyses.
Freshly isolated eosinophils adhere strongly to some glass substrates. In
these circumstances, attachment induces cells to flatten out with activation
and generation of calcium signals (our unpublished observations). To cir-
cumvent these problems we let eosinophils adhere to fibronectin-coated
surfaces with the use of mAb 8A2 or to 7-h TNF-a-activated HUVEC.
Addition of this mAb leads to freezing of b1 integrins in a high-affinity
state and thereby cells strongly attached to fibronectin, but otherwise stay
deactivated, keeping a round shape (35) allowing clear ratio imaging. Eo-
sinophils attached in this way display low intracellular free Ca21 levels
under control condition for long periods of time up to 30 min. In this way,
large numbers of cells could be imaged while being treated with IL-8 and
eotaxin.
All washing and incubation steps were performed in incubation buffer.
Eosinophils (5 3 106/ml) were loaded with 2.5 mM fura 2-AM (Molecular
Probes, Eugene, OR) for 15 min. Hereafter, the cells were incubated in the
absence or presence of 10 mg/ml of the Ab 8A2 for 15 min at 37°C in an
agitated water bath. After washing, 8A2-treated cells (1–2 3 106) were
plated onto fibronectin (0.1 mg/ml in HEPES, 15 min, 37°C)-coated
24-mm cover slips. Seven-hour TNF-a-activated HUVEC cultured on
24-mm cover slips was extensively washed with PBS, and nontreated fura
2-AM-loaded cells were plated on the endothelium. They were allowed to
settle for 15 min on the substrate, and the nonadherent cells were removed
by washing the cover slips. Cover slips were mounted in an open chamber
and placed in a warmed (37°C) metal ring for Calcium Imaging. Stimulants
were added from the top after two prestimulus image ratios. Stimulants
(37°C, at 2 times the concentration) were added to an equal volume (250
ml) of incubation buffer already present in the chamber to obtain a homog-
enous mixture at the start of the ratio imaging.
Measurement of oxygen consumption
Oxygen consumption was measured at 37°C with an oxygen electrode as
described previously (36). In short, eosinophils were resuspended in incu-
bation buffer (2 3 106 cells/ml). PMA (100 ng/ml) was added and oxygen
consumption was measured for 5 min.
Statistical analysis
Results are expressed as mean 6 SEM. Statistical analysis of the data was
performed using a Students t test for paired data. Values of p , 0.05 were
considered to be significant.
Results
Eosinophils exhibit a transient arrest upon IL-8 during rolling
adhesion along TNF-a-activated endothelium
To investigate the effect of IL-8 on rolling eosinophils, freshly
isolated eosinophils were perfused over 7-h TNF-a-activated con-
fluent HUVEC at shear stress 2 dyn/cm2. When eosinophils were
treated with a control anti-HLA class I Ab (W6/32) (Figs. 1A and
2A), the percentage of rolling cells of the total number of adhering
cells (rolling and firmly adherent cells) was 48 6 3%. Upon stim-
ulation with IL-8 (1028 M) the percentage of rolling cells de-
creased to 12 6 3%. After 1 min, the percentage of rolling cells
increased to 28 6 5%. Addition of 20 mg/ml anti-IL-8 Ab to the
IL-8 suspension prevented this transition from rolling to a station-
ary arrest of W6/32-treated (control) eosinophils (Fig. 1A). When
eotaxin (1028 M), a potent chemokine for eosinophils, was added
to the rolling W6/32-treated eosinophils, the percentage of rolling
cells decreased from 56 6 3 to 7 6 3%. The cells bound stable and
long term because after 1 min the percentage of rolling cells was
still very low (8 6 3%) (Figs. 1A and 2B). In addition, the eosin-
ophils flattened upon eotaxin treatment, while this was not seen
upon addition of IL-8. Also, we tested whether eotaxin could in-
duce a stable and long-term arrest when applied to cells that started
FIGURE 1. Effect of perfusion of cytokines on the percentage of rolling
eosinophils on 7-h TNF-a stimulated HUVEC. The percentage of rolling
cells per field for W6/32-, HP2/1-, IB4-, and HP2/11IB4-treated eosino-
phils are depicted. The percentage of rolling cells was determined before
(M), during (f), and 1 min after (o) stimulation. The effect of 1028 M
IL-8, 1028 M IL-8/anti-IL-8, and 1028 M eotaxin on control mAb W6/
32-treated rolling eosinophils (A); 1028 M IL-8, 1028 M IL-8/anti-IL-8,
and 1028 M eotaxin on mAb HP2/1-treated rolling eosinophils (B); and
1028 M IL-8 and 1028 M eotaxin on anti-b2 integrin-treated and both
anti-a4 and b2 integrin-treated eosinophils (C). The percentage of rolling
cells are plotted for three to six experiments 6 SEM, except for W6/32/
IL-8 (n 5 10) and HP2/1/IL-8 (n 5 16). The statistically significant effects
of the different treatments against the situation before treatment were de-
termined by paired Student’s t test (p, p , 0.05).
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rolling again after the IL-8-induced arrest. Indeed, .97% of the
cells were long-term arrested after addition of eotaxin to W6/32-
treated eosinophils, which were rolling after the IL-8-induced tran-
sient arrest.
To investigate whether a4 integrins played a role in this IL-8-
induced arrest, eosinophils were treated with anti-a4 integrin Ab
(HP2/1) (Figs. 1B and 2C). The percentage rolling cells of HP2/
1-treated eosinophils on TNF-a-activated HUVEC was 52 6 5%,
which was significantly higher than W6/32-treated eosinophils,
which was shown in an earlier study (4). The rolling percentages
of all groups are higher in this study compared with an earlier
study (4). This is caused by the increase in the shear stress used in
this study (2 dyn/cm2), whereas the shear stress in the former study
was 0.8 dyn/cm2. Upon stimulation with IL-8 (1028 M) the per-
centage of rolling cells decreased to 14 6 3%. After 1 min, the
percentage rolling cells increased from 14 6 3% to 33 6 5%.
Within 2 min almost all arrested cells (both W6/32 and HP2/1
treated) started rolling again. Addition of 20 mg/ml anti-IL-8 Ab
prevented the IL-8-induced transition from rolling to stationary
arrest of HP2/1-treated eosinophils (Fig. 1B). When 1028 M
eotaxin was added to the rolling HP2/1-treated eosinophils, all
cells bound stable and long term (Fig. 1B). The experiment with
the W6/32- and HP2/1-treated cells shows that the IL-8 effect on
eosinophils can occur independently of the interaction between the
a4b1 integrin with its ligand VCAM-1 on activated endothelium.
To investigate whether b2 integrins are implicated in the IL-8-
induced arrest, eosinophils were incubated with an anti-b2 integrin
mAb IB4. When b2 integrins were blocked, the percentage of roll-
ing cells per field was 66% 6 6. Upon IL-8 stimulation, the per-
centage of rolling cells decreased to 28 6 6%, and after 1 min
increased to 40 6 6% rolling cells again (Fig. 1C). When eotaxin
was added to rolling IB4-treated eosinophils, the percentage of
rolling cells decreased from 64 6 8% to 9 6 3%. After 1 min, the
cells were still firmly adhered to the endothelial cells.
Finally, we investigated the effect of blocking b2 integrins and
a4 integrins simultaneously. When both b2 integrins and a4 inte-
grins were blocked, the percentage of rolling cells was 84 6 4%.
Upon addition of IL-8, all cells kept rolling (80 6 5%). After 1
min, upon addition of IL-8, the percentage of rolling cells was still
85 6 5%. When eotaxin was added to IB4- and HP2/1-treated
eosinophils, no significant changes in the percentage of rolling
cells was observed (Fig. 1C). These data show that the IL-8-in-
duced transient arrest and the eotaxin-induced stable arrest can be
mediated by either b2 or a4 integrins.
To investigate whether the known IL-8 receptors CXCR1 and 2
mediated the IL-8-induced response, eosinophils were incubated
with Abs against the CXCR1 and 2 (6C6 and 5A12 respectively).
IL-8-induced transient arrest was not inhibited and the percentage
of rolling cells decreased from 46 6 10% to 16 6 5% upon IL-8
stimulation (Fig. 3A). The IL-8-induced arrest was transient and
the percentage of rolling cells increased from 16 6 5 to 27 6 11%.
The functionality of these Abs on IL-8 (1028 M)-induced neutro-
phil chemotaxis in a Boyden chamber assay was confirmed by
their ability to block the IL-8-induced migration by 74% as was
also shown by others (27). In Fig. 3, B and C, it is shown that
CXCR1 and 2 are not present on isolated eosinophils, whereas they
are present on neutrophils (40). To address whether the IL-8-in-
duced arrest was mediated by G protein-coupled receptors, eosin-
ophils were incubated with solvent (0, 5% glycerol) or 100 or 500
ng/ml PTX for 2 h. Control glycerol-treated eosinophils arrested
transiently upon IL-8 perfusion comparable with W6/32- and HP2/
1-treated eosinophils. In contrast, eosinophils treated with PTX
showed a dose-dependent inhibition of IL-8-induced arrest (Fig.
3A). To control for possible negative effects of PTX on the normal
physiology of the eosinophils, we performed respiratory burst ex-
periments. Eosinophils incubated with 0.5% glycerol or 500 ng/ml
PTX for 2 h at 37°C were tested for respiratory burst upon acti-
vation of PMA. No differences were found in the PMA-induced
FIGURE 2. Computerized analyses of the effect
of perfusion of cytokines on the percentage of roll-
ing eosinophils on 7-h TNF-a-stimulated HUVEC.
Eosinophils (2 3 106/ml) were incubated with 10
mg/ml of the indicated mAbs before the assay.
Lines indicate the rolling tracks of the cells in one
field during 2 s. Cells are positioned at the begin-
ning of the track. Images depict rolling tracks be-
fore, during, and 1 min after indicated cytokine
stimulation. Data are depicted as representative ex-
periments (see also Fig. 1).
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oxidative burst of glycerol vs PTX-treated eosinophils (not
shown).
Eosinophils bound to fibronectin and endothelium show
significant calcium responses upon IL-8
To investigate the changes in intracellular free Ca21 of adherent
eosinophils upon IL-8 and eotaxin stimulation, cells were incu-
bated with 8A2 and loaded on fibronectin-coated cover slips or
nontreated cells were loaded on 7-h TNF-a-stimulated HUVEC
(see Materials and Methods (35)). After stimulation with 1028 M
IL-8, a clear increase in [Ca21]i (. 200 nM) was observed in 42 6
7% and 30 6 7% of the cells adhering to fibronectin and activated
HUVEC, respectively (Fig. 4, A and B, showing a representative
experiment). The increase in [Ca21]i of cells adherent to fibronec-
tin is depicted in Fig. 5A. When neutralizing Abs for IL-8 (clone
B-K8) were added to the IL-8 solution before addition to the cells,
the change in [Ca21]i response was blocked (Figs. 4A and 5B). A
second IL-8 stimulation given did not elicit a [Ca21]i response
indicating homologous desensitization of the receptor (data not
shown). Upon eotaxin (1028 M) stimulation, 97 6 0.5% and 98 6
1.7% of the cells adhering to fibronectin and activated HUVEC,
respectively, increased their intracellular free Ca21 concentration
(Figs. 4 and 5C).
To investigate whether the IL-8-induced [Ca21]i responses were
sensitive to PTX, eosinophils were incubated with control solution
(glycerol 0, 5%) or 500 ng/ml PTX for 2 h at 37°C. Fig. 6 shows
that the [Ca21]i responses were blocked in PTX-treated cells ad-
hering to fibronectin (Fig. 6A) or 7 h TNF-a-activated HUVEC
(Fig. 6B). Also, the positive control C5A induced a [Ca21]i re-
sponse that was completely blocked by 500 ng/ml PTX.
Discussion
In this article, the hypothesis was tested whether IL-8 can activate
eosinophils when interacting with a physiological relevant sub-
strate such as endothelial cells and/or fibronectin. Therefore, we
first performed in vitro flow chamber experiments and evaluated
the effect of IL-8 on rolling, nonstimulated eosinophils. We
showed that IL-8 induced a transient arrest of eosinophils, which
were rolling on 7-h TNF-a-stimulated HUVEC even when a4 or
b2 integrins were blocked. Only in the presence of blocking Abs
FIGURE 3. A, The effect of inhibition of serpentine receptors on the percentage of rolling eosinophils on 7-h TNF-a-stimulated HUVEC is depicted.
The effect of IL-8 on anti-CXCR1 and 2 Abs (5A12 and 6C6, 15 min, 37°C), control solvent (glycerol 0.5%, 2 h, 37°C), and PTX (100 and 500 ng/ml,
2 h, 37°C)-treated eosinophils was determined before (M), during (f), and 1 min after (o) stimulation. The percentage of rolling cells are plotted for three
to six experiments 6 SEM. The statistically significant effects of the different treatments against the situation before treatment were determined by paired
Student’s t test (p, p , 0.05). B and C, Granulocytes were stained for b2 integrins (IB4, dotted line), CXCR1 (5A12, thick solid line), CXCR2 (6C6, dashed
line), or an irrelevant Ab (thin solid line) by FACS. B and C, The fluorescence for eosinophils and neutrophils, respectively. The experiment shown is
representative for three independent experiments.
FIGURE 4. Effect of adding cytokines to adhering eosinophils on fibronectin. Eosinophils were loaded with 2.5 mM fura 2-AM, incubated with mAb
8A2 (35), and put on fibronectin-coated glasses for 15 min (A) or put on 7-h TNF-a-activated HUVEC for 15 min (B). Nonadhering cells were washed
away. IL-8 (M), eotaxin (l), or IL-8/anti-IL-8 () was added after 2 blanco images () and 48 images were taken at 340 and 380 nm after the addition
of cytokines. [Ca21]i was measured by calculating 340/380 ratios (see Materials and Methods). The figure is representative for three independent
experiments.
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against both a4 and b2 integrins the IL-8-induced arrest was pre-
vented. This shows that IL-8 can transduce signals leading to ac-
tivation of a4 as well as b2 integrins. Furthermore, we conclude
that the chemokines eotaxin and IL-8 act both on a4 and b2 inte-
grins. In contrast to IL-8 activation, eotaxin-induced activation of
the integrins leads to firm adhesion and spreading. Also, Weber et
al. concluded from static adhesion assays that chemoattractants,
like RANTES, regulate the avidity of both b1 and b2 integrins
expressed on the same eosinophil (37).
This is the first report showing that IL-8 affects resting,
unprimed eosinophils in the transition from rolling to firm adhe-
sion (Figs. 1 and 2) and that a chemokine can induce a transient
arrest for a period of 0.5–2 min in the presence of the stimulus.
Recently, Gerszten et al. (38) showed that monocytes, which are
typical C-C chemokine responders, firmly adhere to endothelium
upon stimulation with the CXC chemokine IL-8. In contrast to
eosinophils, monocytes adhered long term to the endothelium upon
IL-8 stimulation. These results suggest that IL-8 is not restricted
for the neutrophil lineage and can have different effects on different
leukocyte subsets. We cannot exclude that activation of the endo-
thelium by TNF-a induces IL-8 secretion or presentation, which
could influence the eosinophil function. However, this seems un-
likely because treatment of the endothelium by anti-IL-8 did not
influence rolling velocity (data not shown) and the HUVEC was
washed extensively before every experiment.
Our results also suggest that at least for unprimed eosinophils an
additional stimulus aside from IL-8 is needed to induce long-term
adhesion. These could be cytokines/chemokines that are associated
with allergic inflammation like IL-5, IL-4, or eotaxin. Indeed, it is
known from in vitro (15, 16) studies that cytokine-activated eosino-
phils migrate in response to IL-8 in contrast to unactivated eosino-
phils. When eosinophils, which started rolling after the IL-8-induced
transient arrest, were subsequently activated by eotaxin, the cells ad-
hered firmly and long term to the endothelium and spreading was
visible. This indicates that IL-8 does not cross desensitize or modulate
the eotaxin-induced response. Long-term adhesion and spreading was
also visible when eotaxin was administered directly to rolling cells
(Figs. 1, B and D, and 2B). This transition between transient and
long-term adhesion allows the control of leukocyte extravasation by
integration of different signals induced by multiple cytokines. The
effect of IL-8 on the arrest of cytokine-primed eosinophils cannot be
addressed because cytokine-primed eosinophils show static adhesion
on activated endothelium (i.e., they do not roll because b2 integrins
are activated) (39).
Activation of leukocytes by chemoattractants is often associated
with an increase in the intracellular free Ca21 concentration. How-
ever, many reports have only shown a small, if any, increase in
[Ca21]i upon IL-8 stimulation of eosinophils (15, 40, 41). These
studies measured the mean increase in [Ca21]i of a large popula-
tion of cells in suspension. Indeed, Petering et al. (41) showed
increasing [Ca21]i responses in eosinophil suspensions to which
increasing concentrations of neutrophils were added, suggesting
that eosinophils in suspension do not raise [Ca21]i upon IL-8 stim-
ulation. From a physiological point of view it is more relevant to
study changes in [Ca21]i in eosinophils adhered to natural relevant
surfaces for several reasons: 1) adhesion changes signaling in
granulocytes (42), and 2) chemokines are often presented by large
carbohydrate structures on the surface of endothelial cells (43).
Therefore, we investigated whether IL-8 would elicit a change in
[Ca21]i in eosinophils when attached to fibronectin and activated
FIGURE 5. Computerized analyses of the effect of adding cytokines to fibronectin-adhering eosinophils. Eosinophils were loaded with 2.5 mM fura
2-AM, incubated with 8A2 and put on fibronectin-coated glasses for 15 min. A, The effect of IL-8 before, during, and after addition. B, The effect of
IL-8/anti-IL-8 before, during, and after addition. C, The effect of eotaxin before, during, and after addition. Data are depicted as a representative of three
experiments (see also Fig. 4A).
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endothelium. We showed that ;40% and ;30% of the eosinophils
adhering to fibronectin by b1 integrin freezing Ab 8A2 and acti-
vated HUVEC, respectively, exhibited an increase in [Ca21]i in
response to IL-8. Petering et al. (41) concluded that contaminating
neutrophils in the eosinophil suspensions caused the IL-8-induced
increase in total [Ca21]i. However, contaminating neutrophils can-
not explain our results for varying reasons. Our eosinophil popu-
lations consisted of ,5% neutrophils while 30–40% of the ad-
hered cells showed a [Ca21]i response upon IL-8 stimulation, and
the contaminating effects of neutrophils were excluded by using
single cell measurement on adhering cells. Moreover, the eosino-
phil-specific eotaxin was added at the end of every experiment to
show that the IL-8 responsive cells were indeed eosinophils.
In the static Ca21 experiments only 30 and 40% of the eosin-
ophils adhering to activated HUVEC and fibronectin, respectively,
were activated by IL-8. In contrast, almost all of the rolling eo-
sinophils responded upon IL-8 in the flow chamber experiments.
This discrepancy is consistent with a hypothesis that the subpopu-
lation of IL-8 responsive cells are prone for an interaction with
cytokine-activated endothelial cells under flow conditions.
We were not able to block the IL-8-induced transient arrest of
eosinophils by Abs against CXCR1 and 2 (5A12 and 6C6 respec-
tively) while the functionality of these Abs was confirmed in mi-
gration assays. Using 5A12 and 6C6, the IL-8 receptors CXCR1
and 2 were not detected by FACS on eosinophils (Fig. 3, b and c).
This is analogous to the data of Petering et al. (41). Therefore, it
is tempting to hypothesize the existence of an unknown IL-8 re-
ceptor on eosinophils. To show that a G protein-coupled receptor
is involved, PTX was added to the eosinophils and this inhibited
the IL-8-induced transient arrest and also the IL-8- and C5A-in-
duced increase in [Ca21]i. This indicates that a PTX-sensitive G-
protein-coupled receptor is mediating the effects of IL-8 on eosin-
ophils.
Our experiments were performed on physiological surfaces ex-
pressing several integrin ligands that might lead to cross linking of
integrins on the cell surface and concomitant cross talk between
these proteins (44). This putative cross-talk between integrins is
not necessary per se for this transient arrest, because blockade of
either Mac-1 or very late Ag-4 does not affect the IL-8-induced
arrest in our flow chamber experiments. However, this does not
mean that cross-talk does not occur. Interestingly, our experiments
shown in Figs. 4 and 6 seem to indicate that possibly cross linking
of integrins by their ligands expressed by different surfaces influ-
ences the kinetics of the IL-8- and/or C5a-induced changes in
[Ca21]i. The IL-8-induced changes in [Ca21]i are remarkably slow
compared with eotaxin and C5a. These latter agonists are in con-
trast to IL-8 very active in increasing [Ca21]i in eosinophils in
suspension (41, 15). Therefore, adhesion mediated by cross-link-
ing of integrins might initiate a permissive signal for the IL-8-
induced rise in [Ca21]i in adherent eosinophils. In addition, the
C5a response has a unexpected sustained behavior in eosinophils
adherent on a surface (i.e., TNF-activated endothelium) that is rich
with different integrin ligands. Again the kinetics of this response
in adherent cells is different compared with the situation in
suspension.
Summarizing, this study shows that resting rolling eosinophils
on 7-h TNF-a-stimulated HUVEC arrest transiently upon IL-8
stimulation at shear rate 2 dyn/cm2. This a4 and b2 integrin-de-
pendent process was not likely to be mediated by the known IL-8
receptors CXCR1 or 2. In addition, ;40 and ;30% of the adhered
eosinophils (to fibronectin and activated endothelium, respec-
tively) increased their [Ca21]i in response to IL-8 stimulation. Our
findings are consistent with a model in which IL-8 can only tran-
siently activate eosinophils provided that they adhere to physio-
logically relevant surfaces. Transient arrest can be shifted easily
into firm long-term arrest by additional chemokines. The transient
arrest of eosinophils upon IL-8 exposure increases the time of
contact between the cell and the endothelial lining, which poten-
tiates the immunological surveillance.
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